- ►physiology.org H Ceulemans, M Bollen - Physiological reviews, 2004 - Am Physiological Soc About one-third of all eukaryotic proteins are controlled by phosphorylation of
specific serine, threonine, and/or tyrosine residues. Most phosphorylations are
reversible, implying that the phosphorylation level of a protein reflects ... Cited by 208 - Related articles - BL Direct - All 7 versions
S Aiston, MP Coghlan, L Agius - European Journal of Biochemistry, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 27 - Related articles - BL Direct - All 5 versions
- ►nih.gov [PDF] T Latsis, B Andersen, L Agius - Biochemical Journal, 2002 - pubmedcentral.nih.gov Two distinct allosteric inhibitors of glycogen phosphorylase, 1,4-dideoxy-1,4-
imino--arabinitol (DAB) and CP-91149 (an indole-2-carboxamide), were
investigated for their effects on the phosphorylation state of the enzyme ... Cited by 25 - Related articles - BL Direct - All 8 versions
AR Green, S Aiston, CC Greenberg, S … - Journal of Biological Chemistry, 2004 - ASBMB Expression of the glycogen-targeting protein PTG promotes glycogen synthase
activation and glycogen storage in various cell types. In this study, we tested
the contribution of phosphorylase inactivation to the glycogenic action of ... Cited by 23 - Related articles - BL Direct - All 5 versions
CC Greenberg, KN Meredith, L Yan, MJ Brady - Journal of Biological Chemistry, 2003 - ASBMB Protein phosphatase-1 (PP1) plays an important role in the regulation of
glycogen synthesis by insulin. Protein targeting to glycogen (PTG) enhances
glycogen accumulation by increasing PP1 activity against ... Cited by 21 - Related articles - BL Direct - All 3 versions
- ►jbc.org CA Worby, MS Gentry, JE Dixon - Journal of Biological Chemistry, 2008 - ASBMB Lafora disease (LD) is an autosomal recessive neurodegenerative disease that
results in progressive myoclonus epilepsy and death. LD is caused by mutations
in either the E3 ubiquitin ligase malin or the dual specificity phosphatase ... Cited by 18 - Related articles - All 5 versions
S Munro, H Ceulemans, M Bollen, J … - FEBS Journal, 2005 - interscience.wiley.com Stimulation of glycogen-targeted protein phosphatase 1 (PP1) activity by insulin
contributes to the dephosphorylation and activation of hepatic glycogen synthase
(GS) leading to an increase in glycogen synthesis. The glycogen-targeting ... Cited by 15 - Related articles - All 5 versions
MG Pezzolesi, M Nam, T Nagase, T Klupa, JS … - Diabetes, 2004 - Am Diabetes Assoc In a panel of large Caucasian pedigrees, we genotyped markers in eight
chromosomal regions previously reported as supporting linkage with type 2
diabetes. We previously reported significant linkage on chromosome 20q ... Cited by 15 - Related articles - BL Direct - All 4 versions
- ►nih.gov [PDF] C Lerín, E Montell, T Nolasco, M García- … - Biochemical Journal, 2004 - pubmedcentral.nih.gov Pharmacological inhibition of liver GP (glycogen phosphorylase), which is
currently being studied as a treatment for Type II (non- insulin-dependent)
diabetes, may affect muscle glycogen meta- bolism. In the present study, we ... Cited by 9 - Related articles - BL Direct - All 7 versions
IR Kelsall, S Munro, I Hallyburton, JL … - FEBS letters, 2007 - Elsevier The inhibition of hepatic glycogen-associated protein phosphatase-1 (PP1-G L )
by glycogen phosphorylase a prevents the dephosphorylation and activation of
glycogen synthase, suppressing glycogen synthesis when glycogenolysis is ... Cited by 8 - Related articles - All 6 versions
